Case consults: Changing paradigms in the age of biologics


    Target audience

    The educational content of this website is aimed at physicians and other healthcare professionals involved in care and treatment of patients with chronic spontaneous urticaria (CSU).

    This eLearning activity is made up of 3 video presentations and 2 video case studies. To claim a certificate of completion you must finish all presentations and achieve a score of 70% in the final assessment.

    Presentation Content


    Welcome and introduction: Burden and impact of chronic urticaria
    Christian Vestergaard


    Case Consult #1: Daniel


    Update of Chronic Urticaria
    Marcus Maurer


    Case Consult #2: Meritxell


    Biologic Therapies in Chronic Urticaria
    Ana Giménez-Arnau

    Educational objectives

    On completion of this activity, learners will be better able to:

    • Identify the burden of chronic urticaria and the impact of sub-optimal treatment
    • Describe the diagnosis and classification of chronic urticaria
    • Select evidence-based treatment options for patients with chronic urticaria based on disease characteristics
    • Summarise the role of biologic therapies in chronic urticaria


  • Christian Vestergaard

    Associate Professor, Department of Dermatology, University of Aarhus, Denmark.

    View More

Honoraria or consultation fees: Novartis.
Participation in a company sponsored speaker’s bureau: Novartis, AbbVie.



  • Marcus Maurer

    Professor of Dermatology and Allergy, Department of Dermatology and Allergy, Allergie-Centrum-Charité at the Charité - Universitätsmedizin Berlin, Germany

    View More

  • Disclosures:
    Marcus Maurer is or recently was a speaker and/or advisor for and/or has received research funding from Almirall Hermal, Bayer Schering Pharma, Biofrontera, Genentech, GSK, Merckle Recordati, Novartis, Sanofi Aventis, Schering Plough, Leo, MSD, Shire, Symbiopharm, UCB and Uriach.



  • Ana Giménez-Arnau

    Ana Giménez-Arnau currently serves as Associate Professor in Dermatology at the Universitat Autonoma and Pompeu Fabra of Barcelona.

    View More

  • Disclosures:
    Medical Advisor for Uriach Pharma, Genentech, Novartis.
    Research Grants supported by Intendis – Bayer, Uriach Pharma, Novartis.
    Educational activities sponsored by Uriach Pharma, Novartis, Genentech, Menarini, GSK, MSD, Almirall, Leo Pharma.



    This activity is supported by funding from Novartis Pharma AG.

    Additional information

    System requirements

    PC Mac

    Microsoft Windows 2000 or above.
    Internet Explorer (v8 or greater), Chrome, Safari or Firefox
    Adobe Acrobat Reader*

    MAC OS 10.2.8
    Safari or Chrome
    Adobe Acrobat Reader*
    Internet Explorer is not supported on the Macintosh.

    *Required to view printable (PDF) version of the completion certificate.


    Login/ Register Maximise Minimise